Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease
Conti, D.J.; Freed, B.M.; Lempert, N.
Transplantation Proceedings 25(1 Part 2): 1421-1422
1993
ISSN/ISBN: 0041-1345 PMID: 8382867 Document Number: 415150
Document emailed within 1 workday
Related Documents
Steinmuller, D.R.; Graneto, D.; Swift, C.; Novick, A.C.; Streem, S.B.; Cunningham, R.J.; Hodge, E.; Bretan, P. 1989: Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation Transplantation Proceedings 21(1 Pt 2): 2069-2071Fassbinder, W.; Bechstein, P.B.; Scheuermann, E.H.; Schoeppe, W. 1985: Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin Scandinavian Journal of Urology and Nephrology. Supplementum 92: 23-28
Lloveras, J.; Puig, J.M.; Oliveras, A.; Orfila, A.; Comerma, I.; Aubia, J.; Masramón, J. 1992: Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA Transplantation Proceedings 24(1): 43-44
Park, K.; Kim, Y.S.; Kim, S.I. 1992: Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea Transplantation Proceedings 24(6): 2426-2427
Madsen, M.; Fjeldborg, O.; Rasmussen, A.; Povlsen, J.V.; Kissmeyer-Nielsen, F. 1990: The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria Transplantation Proceedings 22(4): 1371-1372
Diosi, P.; Moldovan, E.; Rusinaru, D. 1982: Estimation of cytomegalovirus--imposed risks on the outcome of renal transplantation Archives Roumaines de Pathologie Experimentales et de Microbiologie 41(1): 35-41
Waltzer, W.C.; Arnold, A.N.; Anaise, D.; Hurley, S.; Raisbeck, A.; Egelandsdsdal, B.; Pullis, C.; Rapaport, F.T. 1987: Impact of cytomegalovirus infection and HLA-matching on outcome of renal transplantation Transplantation Proceedings 19(5): 4077-4080
Baldwin, W.M.; van Es, A.; Valentijn, R.M.; van Gemert, G.W.; Daha, M.R.; Vanes, L.A. 1982: Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections Clinical and Experimental Immunology 50(3): 515-524
Park, E.S.; Ahn, S.S.; Jung, S.M.; Song, J.J.; Park, Y.-B.; Lee, S.-W. 2018: Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis Clinical and Experimental Rheumatology 36 Suppl 111(2): 115-120
Van den Berg, A.P.; van Son, W.J.; van der Bij, W.; van der Giessen, M.; The, T.H. 1990: Early identification of patients at high risk of severe cytomegalovirus disease after renal transplantation using the immediate early antigenemia assay Transplantation Proceedings 22(4): 1800-1802
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Moreno, J.; Montero, J.L.; Gavilán, F.; Costán, G.; Herrero, C.; Cárdenas, M.; Sánchez-Guijo, P.; Torre-Cisneros, J. 1999: Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients Enfermedades Infecciosas y Microbiologia Clinica 17(8): 382-385
Nunan, T.O.; King, M.; Bull, P.; Banatvala, J.E.; Jones, N.F.; Hilton, P.J. 1984: Parenteral acyclovir therapy for cytomegalovirus infection after renal transplantation Clinical Nephrology 22(1): 28-31
Kapoor, N.; Copelan, E.A.; Tutschka, P.J. 1989: Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent Transplantation Proceedings 21(1 Part 3): 3095-3096
Ratnamohan, V.M.; Chapman, J.; Howse, H.; Bovington, K.; Robertson, P.; Byth, K.; Allen, R.; Cunningham, A.L. 1998: Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation Transplantation 66(7): 877-882
Waid, T.H.; McKeown, J.W. 1995: Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation Transplantation Proceedings 27(5 Suppl 1: 46
Auersvald, L.A.; Perez, R.V.; Lorber, M.I.; Sturges, M.; Friedman, A.L.; Bia, M.J.; Orias, M.; Wilson, J.; Azhderian, E.; Gruber, J. 1995: Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation Transplantation Proceedings 27(6): 3037
Maurer, J.R.; Snell, G.; deHoyos, A.; Kesten, S.; Winton, T. 1993: Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens Transplantation Proceedings 25(1 Part 2): 1434-1435
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Abouna, G.M.; Kumar, M.S.; Stephan, R.; Prior, J.E.; Lyons, P.; Bulova, S.I.; al-Abdullah, I.H. 1993: Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2241-2242